News & Events
April 30, 2019
Huntington’s Disease Regulatory Science Consortium (HD-RSC) Inaugural Meeting SummaryIntroduction Huntington’s Disease Regulatory Science Consortium (HD-RSC) Inaugural Meeting Summary April 29 & 30, 2019 – Rockville, Maryland The Huntington’s Disease Regulatory Science Consortium (HD-RSC), created in partnership with the CHDI Foundation and the Critical Path Institute (C-Path), was formally launched on March 28, 2018 with the primary goal of defining the regulatory science needs in order...
April 24, 2019 - April 25, 2019
Tenth Annual Patient-Reported Outcome Consortium WorkshopApril 24 – 25, 2019 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 On April 24-25, 2019 the Tenth Annual Patient-Reported Outcome Consortium Workshop was held in Silver Spring, Maryland. The overall Workshop objectives were to: Provide an update on FDA’s Clinical Outcome Assessment (COA) Qualification Program and other initiatives; Describe new and emerging...
April 17, 2019 - April 18, 2019
2019 PSTC Japan Safety Biomarker ConferenceSummary With the cooperation and support of RIKEN, NIHS, JSOT and JPMA, the Predictive Safety Testing Consortium (PSTC) of the Critical Path Institute hosted the 2nd PSTC Japan Safety Biomarker Conference from April 17-18, 2019 in Yokohama, Japan. The utilization of biomarkers in guiding drug development decisions through clinical trials and post marketing studies is...
- March 13, 2019 - March 16, 2019
November 13, 2018
Critical Path for Alzheimer’s Disease 2018 Annual Meeting and Regulatory Science WorkshopNovember 13, 2018 Overview and Objectives: The Critical Path for Alzheimer’s Disease (CPAD) is a public-private partnership aimed at creating new tools and methods that can be applied to increase the efficiency of the development process leading to treatments for neurodegenerative diseases that progress to dementia with the shared characteristics of Alzheimer disease (AD), the...